- ICH GCP
- Registro de ensaios clínicos dos EUA
- Ensaio Clínico NCT07293650
PREcision MEDicine In Achalasia (PREMEDIA) (PREMEDIA)
PREcision MEDicina na Acálasia - Um Ensaio Clínico Multicêntrico Randomizado de Não-Inferioridade de POEM Curto Personalizado vs. POEM Padrão para Acálasia Não-Espástica e Um Estudo de Coorte Prospectivo Multicêntrico de POEM Longo Personalizado para Perturbações Espásticas da Motilidade Esofágica
The goal of this clinical trial is to learn if shorter Per-Oral Endoscopic Myotomy (POEM) works as well as a longer POEM in patients with trouble swallowing due to certain conditions. The main question[s] it aims to answer [is/are]:
- Does making a smaller cut in the muscle at the bottom of the esophagus work just as well as making the standard bigger cut in relieving symptoms?
- Does making the smaller cut reduce the side effects of the procedure compared to the standard bigger cut? Researchers will compare the symptoms and side effects of making a shorter cut to the symptoms and side effects of a longer cut.
Participants will allow researchers to access their standard of care information in their medical record, complete questionnaires at up to 6 times over a 2-year period.
Visão geral do estudo
Status
Condições
Intervenção / Tratamento
Descrição detalhada
The investigators will perform a randomized controlled trial to compare two different approaches to Peroral Endoscopic Myotomy (POEM) for treating achalasia (Types I and II) and esophagogastric junction outflow obstruction (EGJOO). The most widely used treatment for achalasia is POEM but the current approach involves a 9 cm (3.5 inch) myotomy (cutting of the muscle) to open up the tight lower esophageal sphincter to promote food delivery from the esophagus to the stomach. This approach is very effective, with success rates of approximately 90% over the short term. However, the investigators believe that POEM does not require a full 9 cm myotomy and that the investigators can cut much less muscle (approximately 4cm/1.25inches) to achieve similar improvement in symptoms but with less long-term complications. Cutting less muscle may result in less acid reflux, which is the Achilles heel of any successful treatment for achalasia. A shorter muscle cut may also result in less of a complication known as blown-out myotomy, which causes failure of the esophagus to empty its contents and is a major cause of long-term symptom relapse. The investigators have designed this study to determine whether the shorter myotomy (4 cm) is equivalent to the longer myotomy (9 cm) in terms if symptom improvement, but with the possibility of less acid reflux and blown-out myotomy.
Given these questions, the investigators will enroll 370 patients in a randomized trial where patients will receive either the short tailored (4cm/1.25 inches) or the standard myotomy (9cm/3.5 inches). All patients will undergo intraoperative assessment of success of the myotomy by using a special tool called the functional lumen imaging probe (FLIP). The FLIP will measure the opening dimensions of the lower esophageal sphincter and ensure that the myotomy is adequately performed so that the lower esophageal sphincter can open to a level that will improve esophageal emptying/swallowing. The investigators will follow patients for 2 years in a manner similar to how the investigators would follow patients after achalasia treatment in standard clinical practice. The investigators will assess whether symptoms are similar and whether or not there are differences in acid reflux and esophageal emptying. Patients will undergo follow up testing with questionnaires at intervals of 3-6 months over two years and they will have reflux testing (measure acid exposure using a capsule placed during endoscopy) between 6-12 months and a barium esophagram (X ray while drinking barium) at 2 years. The most important aim is to prove that the symptoms and outcomes success/failure) between the two approaches are similar (short myotomy is non-inferior) and the Eckardt score will be the primary questionnaire score for this study. The investigators believe that this study will help define the optimal approach to POEM in achalasia and also help us prevent complications in the future.
Additionally, the investigators will also ask participants to provide a sample of the muscle tissue that is typically cut during the POEM. This tissue will help us develop a tissue bank to help other researchers looking into the causes of why achalasia and these other esophageal diseases occur. The participants can opt out of this part and still continue in the randomized controlled trial.
Tipo de estudo
Inscrição (Estimado)
Estágio
- Fase 3
Contactos e Locais
Contato de estudo
- Nome: Elizabeth Yan, BS
- Número de telefone: 312-908-1723
- E-mail: premedia.dcc@northwestern.edu
Estude backup de contato
- Nome: Yasmin Pina, BS
- Número de telefone: 312-503-6459
- E-mail: premedia.dcc@northwestern.edu
Locais de estudo
-
-
Arizona
-
Scottsdale, Arizona, Estados Unidos, 85259
- Ainda não está recrutando
- Mayo Clinic Arizona
-
-
California
-
La Jolla, California, Estados Unidos, 92037
- Recrutamento
- University of California San Diego
-
Investigador principal:
- Rena Yadlapati, MD
-
Contato:
- Alexander Gonsalves, Lead Study Coordinator
- Número de telefone: 858-246-5236
- E-mail: PREMEDIA@health.ucsd.edu
-
-
Colorado
-
Denver, Colorado, Estados Unidos, 80217
- Ainda não está recrutando
- University of Colorado Denver
-
-
Florida
-
Gainesville, Florida, Estados Unidos, 32611
- Recrutamento
- University of Florida
-
Investigador principal:
- Peter Draganov, MD
-
Contato:
- April Goddard, Lead Study Coordinator, PA-C
- Número de telefone: 352-273-9483
- E-mail: DOM-GIResereachTeam@ad.ufl.edu
-
Orlando, Florida, Estados Unidos, 32803
- Ainda não está recrutando
- Adventist Health System/Sunbelt, Inc
-
-
Georgia
-
Atlanta, Georgia, Estados Unidos, 30322
- Recrutamento
- Emory University
-
Investigador principal:
- Anand Jain, MD
-
Contato:
- Halley Fowler, Lead Study Coordinator
- Número de telefone: 404-778-3184
- E-mail: halley.fowler@emory.edu
-
-
Illinois
-
Chicago, Illinois, Estados Unidos, 60611
- Recrutamento
- Northwestern University
-
Investigador principal:
- John Pandolfino, MD
-
Contato:
- Eric Pfannkuche, Lead Study Coordinator
- Número de telefone: 312-926-4525
- E-mail: PREMEDIA@northwestern.edu
-
-
Maryland
-
Baltimore, Maryland, Estados Unidos, 21218
- Ainda não está recrutando
- Johns Hopkins University
-
-
Massachusetts
-
Boston, Massachusetts, Estados Unidos, 02114
- Recrutamento
- Massachusetts General Hospital
-
Contato:
- Madison Paylor, Lead Study Coordinator
- Número de telefone: 617-726-0196
- E-mail: premedia@mgb.org
-
Investigador principal:
- Kyle Staller, MD
-
-
Missouri
-
St Louis, Missouri, Estados Unidos, 63110
- Recrutamento
- Washington University
-
Contato:
- Darren Nix, Lead Study Coordinator
- Número de telefone: 314-273-1432
- E-mail: Premediasurgerytrial@wustl.edu
-
Investigador principal:
- Chandra Gyawali, MD
-
-
New York
-
New York, New York, Estados Unidos, 10065
- Ainda não está recrutando
- Weill Cornell Medical College
-
-
North Carolina
-
Charlotte, North Carolina, Estados Unidos, 28204
- Recrutamento
- Atrium Health/Wake Forest
-
Investigador principal:
- Badih Elmunzer, MD
-
Contato:
- Greg Scarola, Lead Study Coordinator
- Número de telefone: (704) 355-2000
- E-mail: PREMEDIA@advocatehealth.org
-
-
Ohio
-
Cleveland, Ohio, Estados Unidos, 44109
- Recrutamento
- MetroHealth Medical Center
-
Investigador principal:
- Ronnie Fass, MD
-
Contato:
- Stephanie Baker, Lead Study Coordinator
- Número de telefone: 216-778-5736
- E-mail: premedia@metrohealth.org
-
Cleveland, Ohio, Estados Unidos, 44106
- Ainda não está recrutando
- Case Western Reserve University
-
-
Tennessee
-
Nashville, Tennessee, Estados Unidos, 37232
- Recrutamento
- Vanderbilt University Medical Center
-
Investigador principal:
- Dhyanesh Patel, MD
-
Contato:
- Larry Raber, Lead Study Coordinator
- Número de telefone: 615-322-4643
- E-mail: larry.w.raber@vumc.org
-
-
Texas
-
Dallas, Texas, Estados Unidos, 75246
- Recrutamento
- Baylor Scott & White Health
-
Contato:
- Neomy Flores, Lead Study Coordinator
- Número de telefone: 214-820-9704
- E-mail: premedia@bswhealth.org
-
Investigador principal:
- Vani Albertson Konda, MD
-
-
Critérios de participação
Critérios de elegibilidade
Idades elegíveis para estudo
Aceita Voluntários Saudáveis
Gêneros Elegíveis para o Estudo
Descrição
Inclusion Criteria
- Age ≥ 18
- Type I achalasia or type II achalasia or cEGJOO
- Eckardt score > 3
Exclusion Criteria
The following exclusion criteria are for the RCT, but 1-13 below also pertain to the observational study:
- Prior POEM
- Prior surgical treatment for achalasia
- Endoscopic pneumatic dilation or lower esophageal sphincter botulinum toxin (botox) injection within 6 months
- Prior unrelated esophageal or upper gastric surgery, including Roux-en-Y gastric bypass and sleeve gastrectomy
- Prior endoscopic gastroesophageal intervention for obesity or GERD, such endoscopic sleeve gastroplasty or transoral incisionless fundoplication
- Known secondary achalasia related to malignancy (pseudoachalasia)
- Known eosinophilic esophagitis
- Diverticulum (> 2 cm) in distal esophagus
- Megaesophagus
- Fibroinflammatory stricture of the esophagus due to any etiology (e.g., peptic, radiation, eosinophilic)
- Pregnancy
- Standard contraindications to general anesthesia
- Standard contraindications to endoscopic myotomy in the esophagus (e.g. untreated varices)
- Unwillingness or inability to consent for the study
- Anticipated inability to follow protocol
- Weekly (or more frequent) opioid medication use in the last 2 years
Plano de estudo
Como o estudo é projetado?
Detalhes do projeto
- Finalidade Principal: Tratamento
- Alocação: Randomizado
- Modelo Intervencional: Atribuição Paralela
- Mascaramento: Quadruplicar
Armas e Intervenções
Grupo de Participantes / Braço |
Intervenção / Tratamento |
|---|---|
|
Comparador Ativo: Miotomia Padrão
|
Myotomy during POEM of 8-10 cm in length, extending 2-3 cm into the gastric cardia; intention to perform selective circular myotomy, but allowing full thickness myotomy. FLIP is used to confirm adequate myotomy. |
|
Experimental: Miotomia Curta Personalizada
|
Myotomy during POEM of 4-5 cm in length, extending 1-2 cm into the gastric cardia; intend to perform selective circular myotomy, but allowing full thickness myotomy. FLIP is used to confirm adequate myotomy. |
O que o estudo está medindo?
Medidas de resultados primários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Clinical Response-Overall
Prazo: From enrollment to Year 2
|
Clinical Response is defined by the Eckardt score (a 4-item self-report scale measuring weight loss, chest pain, regurgitation, and dysphagia) with no need for retreatment in 2 years. |
From enrollment to Year 2
|
|
Clinical Response-by Sex
Prazo: From enrollment to Year 2
|
Clinical Response is defined by the Eckardt score (a 4-item self-report scale measuring weight loss, chest pain, regurgitation, and dysphagia) with no need for retreatment in 2 years. |
From enrollment to Year 2
|
|
Clinical Response-by Race
Prazo: From Enrollment to Year 2
|
Clinical Response is defined by the Eckardt score (a 4-item self-report scale measuring weight loss, chest pain, regurgitation, and dysphagia) with no need for retreatment in 2 years. |
From Enrollment to Year 2
|
|
Clinical Response-by Ethnicity
Prazo: From Enrollment to Year 2
|
Clinical Response is defined by the Eckardt score (a 4-item self-report scale measuring weight loss, chest pain, regurgitation, and dysphagia) with no need for retreatment in 2 years. |
From Enrollment to Year 2
|
Colaboradores e Investigadores
Patrocinador
Datas de registro do estudo
Datas Principais do Estudo
Início do estudo (Real)
Conclusão Primária (Estimado)
Conclusão do estudo (Estimado)
Datas de inscrição no estudo
Enviado pela primeira vez
Enviado pela primeira vez que atendeu aos critérios de CQ
Primeira postagem (Real)
Atualizações de registro de estudo
Última Atualização Postada (Real)
Última atualização enviada que atendeu aos critérios de controle de qualidade
Última verificação
Mais Informações
Termos relacionados a este estudo
Termos MeSH relevantes adicionais
Outros números de identificação do estudo
- PREMEDIA (Pro00083748) - 01
Plano para dados de participantes individuais (IPD)
Planeja compartilhar dados de participantes individuais (IPD)?
Tipo de informação de suporte de compartilhamento de IPD
- PROTOCOLO DE ESTUDO
- SEIVA
- CSR
Informações sobre medicamentos e dispositivos, documentos de estudo
Estuda um medicamento regulamentado pela FDA dos EUA
Estuda um produto de dispositivo regulamentado pela FDA dos EUA
Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .